Today: 9 June 2026
3M stock slips 1.6% into Presidents Day break as dividend date hits and insider sales surface
15 February 2026
2 mins read

3M stock slips 1.6% into Presidents Day break as dividend date hits and insider sales surface

New York, Feb 14, 2026, 18:27 EST — The market has closed.

  • 3M fell 1.6% to finish Friday at $171.82, giving back gains after Thursday’s intraday jump that nearly hit $177.41.
  • The stock went ex-dividend for its $0.78 quarterly payout, which is set for March 12.
  • SEC filings this week revealed that executives, along with a former officer, have conducted share sales and settled tax-withholding obligations through transactions.

3M Co slid 1.6% Friday, closing out the session at $171.82 after hitting an intraday high of $177.41 in the previous session. The Dow name opened at $174.50 and slipped to $170.57 at its low, with roughly 3.18 million shares traded as the stock approached a long U.S. market weekend.

This timing matters because Friday marked 3M’s ex-dividend date, meaning fresh buyers lost eligibility for the upcoming payout—a factor that can drag the stock down by about the dividend’s value. The board set a first-quarter dividend at $0.78 per share, with payment slated for March 12 to holders on record as of Feb. 13, according to the company.

The drop came as U.S. markets showed more nerves around both interest rates and the dominant tech names. On Friday, the S&P 500 eked out a small gain following softer inflation numbers, but the Nasdaq ended lower—tech giants dragging it down again, Reuters said. Traders remained cautious ahead of Monday’s Presidents Day break. “Large cap tech stocks continue to be an anchor on the market and any whiff of optimism continues to get rejected,” said Michael James, managing director at Rosenblatt Securities. Reuters

Senior Vice President and Chief Administrative Officer Theresa E. Reinseth sold a total of 5,145 shares on Feb. 11, according to a Form 4. The transactions went through at roughly $172.7 per share. Reinseth also exercised options for 3,349 shares in the same window, and now holds about 2,584.5834 shares directly. The Form 144 listed the anticipated sale value at approximately $889,000.

Group President Beatriz Karina Chavez Rodriguez, in an amended Form 4, reported that 2,306 shares were withheld for taxes at $172.65, noting the filing now reflects the “actual number of shares withheld.” Over in a separate Form 144 from Feb. 12, former officer Victoria Clarke listed a planned sale of 1,041 shares. 3M Company

Friday morning saw 3M and Goldman Sachs weighing on the Dow, MarketWatch reported, with pressure from stocks like Nvidia, Verizon, and Cisco adding to the index’s slide.

Bulls have something to watch: if hopes for rate cuts slip or sentiment turns negative on growth and spending, the dividend adjustment could spiral into deeper trouble. Back in January, 3M was looking for $8.50 to $8.70 a share in adjusted profit for 2026 even as it flagged patchy demand. CFO Anurag Maheshwari put it this way—the company sees “the macro in 2026 to be a little bit better.” Reuters

U.S. markets are closed Monday. Eyes turn to Tuesday, when trading picks back up, followed by Wednesday’s release of the Federal Reserve’s Jan. 27-28 meeting minutes, set for 2:00 p.m. in Washington, according to the calendar.

3M holders are watching to see if the stock can find its footing after the ex-dividend drop and last week’s pop—or if selling pressure keeps up through the shortened week.

Investors are eyeing the March 12 dividend payout next, before shifting focus to the upcoming earnings release—where they’ll be searching for new clues on margins, demand, and how quickly management’s turnaround strategy is taking hold.

Stock Market Today

  • Pro Portfolio Adds Broadcom and Netflix Shares, Upgrades Broadcom Rating
    June 9, 2026, 10:19 AM EDT. The Pro Portfolio is buying 80 shares of Broadcom (AVGO) at around $405, increasing its holdings to 512 shares (3.4% of the portfolio). It is also purchasing 372 shares of Netflix (NFLX) near $82.35, increasing its stake to 2,107 shares (2.85%). Broadcom's AI chip forecast for H2 2026 is viewed as conservative following a $35 billion private credit deal involving Apollo and Blackstone. The rating for Broadcom is upgraded to One, with a checkpoint price of $330 maintained. Netflix's shares are seen as undervalued despite recent declines, supported by a $25 billion buyback and rising U.S. viewership. Netflix's ad business shows growth potential, reaching 250 million monthly active viewers, reinforcing optimism amidst concerns over consumer spending.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Charles Schwab stock slips despite $27.8 billion January inflows as investors brace for Fed minutes
Previous Story

Charles Schwab stock slips despite $27.8 billion January inflows as investors brace for Fed minutes

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop